May 14, 2020 / 9:09 PM / 2 months ago

BRIEF-Phio Pharma Presents Data On Intasyl To Improve Cell-Based Immunotherapy At ASGCT 2020

May 14 (Reuters) - Phio Pharmaceuticals Corp:

* PHIO PHARMACEUTICALS - PRESENTS DATA ON INTASYL AS AN ALTERNATIVE TO GENETIC MODIFICATION TO IMPROVE CELL-BASED IMMUNOTHERAPY AT ASGCT 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below